0001819113-23-000033.txt : 20230502
0001819113-23-000033.hdr.sgml : 20230502
20230502162037
ACCESSION NUMBER: 0001819113-23-000033
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230428
FILED AS OF DATE: 20230502
DATE AS OF CHANGE: 20230502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pellizzari Christine A
CENTRAL INDEX KEY: 0001127430
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39727
FILM NUMBER: 23879356
MAIL ADDRESS:
STREET 1: 10 FINDERNE AVENUE
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER NAME:
FORMER CONFORMED NAME: PELLIZZARI CHRISTINE A
DATE OF NAME CHANGE: 20001030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Science 37 Holdings, Inc.
CENTRAL INDEX KEY: 0001819113
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 844278203
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 PARK OFFICES DRIVE
STREET 2: SUITE 3606
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: (984) 377-3737
MAIL ADDRESS:
STREET 1: 800 PARK OFFICES DRIVE
STREET 2: SUITE 3606
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: Lifesci Acquisition II Corp.
DATE OF NAME CHANGE: 20200723
4
1
wf-form4_168305881849181.xml
FORM 4
X0407
4
2023-04-28
0
0001819113
Science 37 Holdings, Inc.
SNCE
0001127430
Pellizzari Christine A
800 PARK OFFICES DRIVE, SUITE 3606
RESEARCH TRIANGLE PARK
NC
27709
0
1
0
0
Chief Legal and HR Officer
0
Common Stock
2023-04-28
4
A
0
702332
A
709832
D
Stock Option
9.49
2023-04-28
4
D
0
1270739
D
2031-07-20
Common Stock
1270739.0
0
D
Stock Option
11.47
2023-04-28
4
D
0
238095
D
2032-01-07
Common Stock
238095.0
0
D
Stock Option
10.05
2023-04-28
4
D
0
247000
D
2031-10-07
Common Stock
247000.0
0
D
On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 1,270,739 shares of common stock of the issuer and in exchange issued to the reporting person 508,295 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.
On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 238,095 shares of common stock of the issuer and in exchange issued to the reporting person 95,237 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.
On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 247,000 shares of common stock of the issuer and in exchange issued to the reporting person 98,800 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.
Includes 2,500 shares acquired under the issuer's Employee Stock Purchase Plan.
Includes 702,332 restricted stock units, which will vest in three equal annual installments beginning on April 28, 2024, subject to continued employment.
The total amount has been adjusted to add 29 derivative securities that were not previously included due to a rounding error.
/s/ Christine Pellizzari
2023-05-02